{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T09:37:56Z","timestamp":1788255476842,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.vaccine.2012.02.004","type":"journal-article","created":{"date-parts":[[2012,2,21]],"date-time":"2012-02-21T06:17:07Z","timestamp":1329805027000},"page":"2778-2785","source":"Crossref","is-referenced-by-count":5,"title":["Molecular investigations into vaginal immunization with HIV gp41 antigenic construct H4A in a quick release solid dosage form"],"prefix":"10.1016","volume":"30","author":[{"given":"Aditya","family":"Pattani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul F.","family":"McKay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda M.","family":"Curran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"McCaffrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prem N.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Lowry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky L.","family":"Kett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin J.","family":"Shattock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen O.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Karl","family":"Malcolm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.02.004_bib0005","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1136\/bmj.322.7300.1475","article-title":"ABC of AIDS \u2013 HIV infection and AIDS in the developing world","volume":"322","author":"Grant","year":"2001","journal-title":"Br Med J"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0010","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(06)69157-5","article-title":"HIV\/AIDS epidemiology, pathogenesis, prevention, and treatment","volume":"368","author":"Simon","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0015","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/bmj.324.7331.207","article-title":"Reducing heterosexual transmission of HIV in poor countries","volume":"324","author":"Lamptey","year":"2002","journal-title":"Br Med J"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0020","first-page":"3","article-title":"Facing the HIV\/AIDS pandemic","volume":"57","author":"Lamptey","year":"2002","journal-title":"Popul Bull"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0025","unstructured":"UNAIDS. Global Report \u2013 UNAIDS Report on the Global AIDS Epidemic. 2010."},{"key":"10.1016\/j.vaccine.2012.02.004_bib0030","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nm0703-847","article-title":"Transmission, acute HIV-1 infection and the quest for strategies to prevent infection","volume":"9","author":"Pope","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jaci.2008.03.036","article-title":"Critical issues in mucosal immunity for HIV-1 vaccine development","volume":"122","author":"Haynes","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0040","doi-asserted-by":"crossref","first-page":"23883","DOI":"10.1074\/jbc.270.41.23883","article-title":"The role of human-immunodeficiency-virus type-1 envelope glycoproteins in virus-infection","volume":"270","author":"Freed","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0045","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0092-8674(00)80205-6","article-title":"Core structure of gp41 from the HIV envelope glycoprotein","volume":"89","author":"Chan","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0050","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nature05580","article-title":"Structural definition of a conserved neutralization epitope on HIV-1 gp120","volume":"445","author":"Zhou","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0055","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1016\/j.vaccine.2009.08.088","article-title":"Vaginal delivery of the recombinant HIV-1 clade-C trimeric gp140 envelope protein CN54gp140 within novel rheologically structured vehicles elicits specific immune responses","volume":"27","author":"Curran","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0060","doi-asserted-by":"crossref","unstructured":"Donnelly L, Curran RM, Tregoning JS, McKay PF, Cole T, Morrow RJ et al. Intravaginal immunization using the recombinant HIV-1 clade-C trimeric envelope glycoprotein CN54gp140 formulated within lyophilized solid dosage forms. Vaccine; 29:4512-4520.","DOI":"10.1016\/j.vaccine.2011.04.023"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0065","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.vaccine.2010.12.034","article-title":"Antibody responses after intravaginal immunisation with trimeric HIV-1(CN54) clade C gp140 in Carbopol gel are augmented by systemic priming or boosting with an adjuvanted formulation","volume":"29","author":"Cranage","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0070","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/mi.2009.110","article-title":"Repeated vaginal administration of trimeric HIV-1 clade C gp140 induces serum and mucosal antibody responses","volume":"3","author":"Cranage","year":"2010","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0075","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.4049\/jimmunol.165.9.5077","article-title":"Vaginal mucosa serves as an inductive site for tolerance","volume":"165","author":"Black","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0080","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.vaccine.2004.11.009","article-title":"Immune response versus mucosal tolerance to mucosally administered antigens","volume":"23","author":"Mestecky","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0085","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0264-410X(96)00259-9","article-title":"Mucosal immunization with a DNA vaccine induces immune responses against HIV-1 at a mucosal site","volume":"15","author":"Wang","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jconrel.2005.09.014","article-title":"AIDS vaccine: intranasal immunization using inactivated HIV-1-capturing core-corona type polymeric nanospheres","volume":"109","author":"Akagi","year":"2005","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0095","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/jmv.10279","article-title":"Mucosal immunization with inactivated HIV-1-capturing nanospheres induces a significant HIV-1-specific vaginal antibody response in mice","volume":"69","author":"Akagi","year":"2003","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0100","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/jmv.2144","article-title":"Induction of mucosal IgA following intravaginal administration of inactivated HIV-1-capturing nanospheres in mice","volume":"66","author":"Kawamura","year":"2002","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0105","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1126\/science.1360702","article-title":"Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein","volume":"258","author":"Lehner","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0110","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S1286-4579(02)01585-X","article-title":"Humoral immune responses to microbial infections in the genital tract","volume":"4","author":"Russell","year":"2002","journal-title":"Microb Infect"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0115","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1046\/j.1365-3083.1996.d01-320.x","article-title":"Local intravaginal vaccination of the female genital tract","volume":"44","author":"Wassen","year":"1996","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0120","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1128\/IAI.65.4.1387-1394.1997","article-title":"Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women","volume":"65","author":"Kozlowski","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0125","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1086\/318839","article-title":"Vaginal mucosal immunization for recurrent urinary tract infection: extended phase II clinical trial","volume":"183","author":"Uehling","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0130","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1128\/CDLI.12.3.447-452.2005","article-title":"Kinetics of local and systemic immune responses after vaginal immunization with recombinant cholera toxin B subunit in humans","volume":"12","author":"Wassen","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0135","first-page":"121","article-title":"Secretory immune-responses in mouse vaginal fluid after pelvic, parenteral or vaginal immunization","volume":"70","author":"Thapar","year":"1990","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0140","doi-asserted-by":"crossref","first-page":"5539","DOI":"10.1128\/IAI.68.10.5539-5545.2000","article-title":"Generation of female genital tract antibody responses by local or central (common) mucosal immunization","volume":"68","author":"Wu","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0145","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.1128\/IAI.66.12.5889-5896.1998","article-title":"Specific-antibody-secreting cells in the rectums and genital tracts of nonhuman primates following vaccination","volume":"66","author":"Eriksson","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0150","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S0264-410X(99)00416-8","article-title":"Effect of route of vaccination with vaccinia virus expressing HSV-2 glycoprotein D on protection from genital HSV-2 infection","volume":"18","author":"Bernstein","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0155","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1440-1711.2002.01051.x","article-title":"Route of administration of chimeric BPV1VLP determines the character of the induced immune responses","volume":"80","author":"Liu","year":"2002","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0160","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/S0264-410X(97)00026-1","article-title":"Commensal bacteria as vectors for mucosal vaccines against sexually transmitted diseases: vaginal colonization with recombinant streptococci induces local and systemic antibodies in mice","volume":"15","author":"Medaglini","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0165","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0010-7824(99)00010-4","article-title":"A vaginal fluid simulant","volume":"59","author":"Owen","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0170","doi-asserted-by":"crossref","first-page":"e8805","DOI":"10.1371\/journal.pone.0008805","article-title":"Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals","volume":"5","author":"Corti","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0175","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.jpba.2009.12.004","article-title":"Selection of an analytical method for evaluating bovine serum albumin concentrations in pharmaceutical polymeric formulations","volume":"51","author":"Umrethia","year":"2010","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0180","first-page":"2","article-title":"The role of CD103+ dendritic cells in the intestinal mucosal system","author":"Ruane","year":"2011","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0185","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1136\/gut.2008.175166","article-title":"Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells","volume":"58","author":"Iliev","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0190","first-page":"583","article-title":"IgA B cell development","volume":"vol. 1","author":"Strober","year":"2005"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0195","series-title":"Mucosal immunology","first-page":"539","article-title":"TH1\/TH2\/TH3 cells for regulation of mucosal immunity, tolerance and inflammation","author":"Kohtaro","year":"2005"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0200","first-page":"14","article-title":"Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production","volume":"182","author":"Sonoda","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0205","first-page":"32","article-title":"Interleukin-5 induces maturation but not class switching of surface IgA-Positive-B Cells into IgA-secreting cells","volume":"66","author":"Matsumoto","year":"1989","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0210","series-title":"Pharmaceutical formulation development of peptides and proteins","first-page":"89","article-title":"Physical stability of proteins","author":"Brange","year":"2000"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0215","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1023\/A:1023263203188","article-title":"Effective inhibition of mannitol crystallization in frozen solutions by sodium chloride","volume":"20","author":"Telang","year":"2003","journal-title":"Pharm Res"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0220","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/jctb.5010030607","article-title":"Acid and alkaline hydrolysis of gelatin","volume":"3","author":"Croome","year":"1953","journal-title":"J Appl Chem"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0225","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0169-409X(95)00049-D","article-title":"The common mucosal immune system for the reproductive tract: basic principles applied toward an AIDS vaccine","volume":"18","author":"Kiyono","year":"1995","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2012.02.004_bib0230","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/mi.2009.89","article-title":"HIV-1 gp41-specific monoclonal mucosal IgAs derived from highly exposed but IgG-seronegative individuals block HIV-1 epithelial transcytosis and neutralize CD4(+) cell infection: an IgA gene and functional analysis","volume":"2","author":"Tudor","year":"2009","journal-title":"Mucosal Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12001685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12001685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T19:45:13Z","timestamp":1593719113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12001685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":46,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0264410X12001685"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.02.004","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}